Anil Kapur Insider Profile

4 Followers
Anil Kapur, Chief Commercial Officer at Actinium Pharmaceuticals, holds ― shares in Actinium Pharmaceuticals (Ticker: ATNM), holds 8.33K shares in Verastem (Ticker: VSTM), holds 0.00 shares in Geron (Ticker: GERN). Most recently, Anil Kapur ― shares of Actinium Pharmaceuticals on ― for an estimated value of ―.
tipranks
Anil Kapur

Anil Kapur
Actinium Pharmaceuticals (ATNM)
Chief Commercial Officer

Not Ranked
Anil Kapur has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$25K
100.00%
0.00%
0.00%
A breakdown of Anil Kapur's holdings

Insider Roles

Verastem
(VSTM)
Director
Actinium Pharmaceuticals
(ATNM)
Chief Commercial Officer
Geron
(GERN)
EVP, Corp Strategy & CCO
Roles that Anil Kapur holds in companies

Most Profitable Insider Trade

Stock:
Geron
(GERN)
Rating:Informative Sell
Date:Jun 12, 2024 - Today
Return:+9.60%
The most profitable trade made by Anil Kapur

Anil Kapur's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Actinium Pharmaceuticals
Chief Commercial Officer
Geron
Jun 12, 2024
EVP, Corp Strategy & CCO
Uninformative Buy
447.19K
$0.00
Verastem
Jun 20, 2024
Director
Uninformative Buy
$24.67K
List of latest transactions for each holding click on a transaction to see Anil Kapur's performance on stock

Anil Kapur insider profile FAQ

What is the percentage of profitable transactions made by Anil Kapur?
The percentage of profitable transactions made by Anil Kapur is ―.
    What is the average return per transaction made by Anil Kapur?
    The average return per transaction made by Anil Kapur is ―.
      What stocks does Anil Kapur hold?
      Anil Kapur holds: ATNM, GERN, VSTM stocks.
        What was Anil Kapur’s latest transaction?
        Anil Kapur latest transaction was an Uninformative Buy of ―.
          What was Anil Kapur's most profitable transaction?
          Anil Kapur’s most profitable transaction was an Informative Sell of GERN stock on June 12, 2024. The return on the trade was 9.60%.
            What is Anil Kapur's role in Actinium Pharmaceuticals?
            Anil Kapur's role in Actinium Pharmaceuticals is Chief Commercial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.